Mar. 6 at 2:10 AM
$OPRX OptimizeRx reports Q4 EPS 51c, consensus 22c
Reports Q4 revenue
$32.24M, consensus
$30.91M. Stephen Silvestro, OptimizeRx CEO commented, "We delivered a strong fourth quarter, exceeding both consensus and internal expectations, with revenue of
$32.2 million and adjusted EBITDA of
$12.0 million. For the full year, revenue reached a record
$109.4 million and adjusted EBITDA totaled
$24.3 million, reflecting more than 20% margin and nearly
$19 million in operating cash flow. Importantly, one year ago, we set a goal to become a Rule of 40 company and we have, in 2025, achieved this benchmark demonstrating the strength of our profitable growth model and the durability of our platform. We continue to be focused on becoming a sustainable Rule of 40 company over the next few years."
